[go: up one dir, main page]

WO2009063885A1 - Grifola frondosa extract and composition containing the same for promoting the production of hyaluronic acid (hyaluronan) - Google Patents

Grifola frondosa extract and composition containing the same for promoting the production of hyaluronic acid (hyaluronan) Download PDF

Info

Publication number
WO2009063885A1
WO2009063885A1 PCT/JP2008/070549 JP2008070549W WO2009063885A1 WO 2009063885 A1 WO2009063885 A1 WO 2009063885A1 JP 2008070549 W JP2008070549 W JP 2008070549W WO 2009063885 A1 WO2009063885 A1 WO 2009063885A1
Authority
WO
WIPO (PCT)
Prior art keywords
hyaluronan
production
same
hyaluronic acid
promoting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/070549
Other languages
French (fr)
Japanese (ja)
Inventor
Masao Takahashi
Akira Ito
Takashi Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HEIMAT CO Ltd
Original Assignee
HEIMAT CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HEIMAT CO Ltd filed Critical HEIMAT CO Ltd
Priority to HK11100066.6A priority Critical patent/HK1145811B/en
Priority to CN2008801158142A priority patent/CN101854943B/en
Priority to JP2009541142A priority patent/JP4583501B2/en
Publication of WO2009063885A1 publication Critical patent/WO2009063885A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

To provide a Grifola frondosa extract which more effectively promotes the production of hyaluronic acid (hyaluronan) and a composition containing the same. A G. frondosa extract obtained by extracting dry G. frondosa with pure ethanol and a composition for promoting the production of hyaluronic acid (hyaluronan) which contains the same.
PCT/JP2008/070549 2007-11-13 2008-11-12 Grifola frondosa extract and composition containing the same for promoting the production of hyaluronic acid (hyaluronan) Ceased WO2009063885A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
HK11100066.6A HK1145811B (en) 2007-11-13 2008-11-12 Grifola frondosa extract and composition containing the same for promoting the production of hyaluronic acid (hyaluronan)
CN2008801158142A CN101854943B (en) 2007-11-13 2008-11-12 Grifola frondosa extract and composition containing the same for promoting the production of hyaluronic acid (hyaluronan)
JP2009541142A JP4583501B2 (en) 2007-11-13 2008-11-12 Maitake extract and composition for promoting hyaluronic acid (hyaluronan) production containing the same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-293998 2007-11-13
JP2007293998 2007-11-13

Publications (1)

Publication Number Publication Date
WO2009063885A1 true WO2009063885A1 (en) 2009-05-22

Family

ID=40638734

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/070549 Ceased WO2009063885A1 (en) 2007-11-13 2008-11-12 Grifola frondosa extract and composition containing the same for promoting the production of hyaluronic acid (hyaluronan)

Country Status (4)

Country Link
JP (1) JP4583501B2 (en)
CN (1) CN101854943B (en)
TW (1) TWI423810B (en)
WO (1) WO2009063885A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014008353A2 (en) 2012-07-05 2014-01-09 Nutramax Laboratories, Inc. Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder
FR3029789A1 (en) * 2014-12-10 2016-06-17 Greenpharma Sas USE OF A PAPAVER EXTRACT AND COMPOSITION PERMITTING SAID USE
WO2022251524A1 (en) 2021-05-26 2022-12-01 Nutramax Laboratories, Inc. Compositions comprising sulforaphane or a sulforaphane precursor and moringa plant components

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104323951A (en) * 2014-11-14 2015-02-04 成都鹏翔生物科技有限公司 Pure natural low-irritation decontamination cleansing milk and preparation method thereof
CN104398425A (en) * 2014-11-14 2015-03-11 成都鹏翔生物科技有限公司 Natural sunscreen cream containing polyporus frondosus extractive
CN106912904B (en) * 2017-03-15 2020-09-08 福建农林大学 Preparation method of full active substance of grifola frondosa and product thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02121905A (en) * 1988-10-30 1990-05-09 Narisu Keshohin:Kk Cosmetic
JPH11263732A (en) * 1998-03-16 1999-09-28 Ichimaru Pharcos Co Ltd Skin preparation for external use containing mushroom extracts
JP2000319192A (en) * 1999-05-03 2000-11-21 Kirindo:Kk Enzyme inhibitor
JP2004501974A (en) * 2000-07-06 2004-01-22 コグニス・フランス・ソシエテ・アノニム Use of the extract of the fungus Grifola flondosa
WO2007142130A1 (en) * 2006-06-02 2007-12-13 Heimat Co., Ltd. Maitake mushroom extract and composition for enhancing the production of sebum comprising the extract

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01159581A (en) * 1987-12-16 1989-06-22 Sekine:Kk Thermostatic decompression drier
JP2909825B2 (en) * 1988-05-20 1999-06-23 株式会社ナリス化粧品 Cosmetics
JP2002034494A (en) * 2000-07-19 2002-02-05 Maitake Hanbai Kk Dry mushroom
JP4078402B2 (en) * 2002-03-08 2008-04-23 株式会社雪国まいたけ Animal feed additive
JP2007142130A (en) * 2005-11-18 2007-06-07 Elpida Memory Inc Exposure device and exposure method

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02121905A (en) * 1988-10-30 1990-05-09 Narisu Keshohin:Kk Cosmetic
JPH11263732A (en) * 1998-03-16 1999-09-28 Ichimaru Pharcos Co Ltd Skin preparation for external use containing mushroom extracts
JP2000319192A (en) * 1999-05-03 2000-11-21 Kirindo:Kk Enzyme inhibitor
JP2004501974A (en) * 2000-07-06 2004-01-22 コグニス・フランス・ソシエテ・アノニム Use of the extract of the fungus Grifola flondosa
WO2007142130A1 (en) * 2006-06-02 2007-12-13 Heimat Co., Ltd. Maitake mushroom extract and composition for enhancing the production of sebum comprising the extract

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014008353A2 (en) 2012-07-05 2014-01-09 Nutramax Laboratories, Inc. Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder
EP3666277A1 (en) 2012-07-05 2020-06-17 Nutramax Laboratories, Inc. Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder
EP4620532A2 (en) 2012-07-05 2025-09-24 Nutramax Laboratories, Inc. Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder
FR3029789A1 (en) * 2014-12-10 2016-06-17 Greenpharma Sas USE OF A PAPAVER EXTRACT AND COMPOSITION PERMITTING SAID USE
WO2022251524A1 (en) 2021-05-26 2022-12-01 Nutramax Laboratories, Inc. Compositions comprising sulforaphane or a sulforaphane precursor and moringa plant components

Also Published As

Publication number Publication date
TW200927157A (en) 2009-07-01
TWI423810B (en) 2014-01-21
CN101854943B (en) 2012-10-10
JPWO2009063885A1 (en) 2011-03-31
HK1145811A1 (en) 2011-05-06
CN101854943A (en) 2010-10-06
JP4583501B2 (en) 2010-11-17

Similar Documents

Publication Publication Date Title
WO2007121443A3 (en) Differentiation of multi-lineage progenitor cells to respiratory epithelial cells
GB2477385B (en) Production of 2,3-butanediol in yeasts
WO2010088633A3 (en) Novel cell lines and methods
WO2009015343A3 (en) Differentiation of multi-lineage progenitor cells to chondrocytes
WO2009061746A3 (en) Process for integrating cellulose and starch feedstocks in ethanol production
EG25240A (en) Electrolysis cell for the production of aluminium comprising means to reduce the voltage drop.
WO2009063885A1 (en) Grifola frondosa extract and composition containing the same for promoting the production of hyaluronic acid (hyaluronan)
WO2011074784A3 (en) Cu-in-zn-sn-(se,s)-based thin film for solar cell and preparation method thereof
PL2517286T3 (en) Separator film, its production process, supercondenser, battery and condensor containing this film
WO2010128518A3 (en) Novel process for the preparation of cisatracurium besylate
WO2011156212A3 (en) Methods to degrade sludge from pulp and paper manufacturing
MY158474A (en) Multistage cellulose hydrolysis and quench with or without acid
ZA201108496B (en) System for treatment of biomass to facilitate the production of ethanol
WO2009143241A3 (en) Differentiation of multi-lineage progenitor cells to pancreatic cells
TW200806304A (en) Maitake mushroom extract and composition containing the same for enhance production of sebum
GB201008401D0 (en) Novel process
WO2010129708A3 (en) Methods and compositions related to the regulation of goblet cell differentiation, mucus production and mucus secretion
WO2010060096A3 (en) Compositions and methods for increasing cellulose production
WO2010083464A3 (en) Methods of detecting cervical cancer
WO2010019386A3 (en) Protein production in plant cells and associated methods and compositions
HK1210436A1 (en) Novel cell compositions and methods
AU2008903886A0 (en) Improved "timber-finishing" process (applicable to all types of timber)
WO2010079404A3 (en) An improved process for the preparation of duloxetine and salts thereof
AU2007904653A0 (en) Hydrogen production by the solar driven electrolysis of sulfurous acid
AU2009906105A0 (en) Improvements to utility knives

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880115814.2

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08849250

Country of ref document: EP

Kind code of ref document: A1

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2009541142

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08849250

Country of ref document: EP

Kind code of ref document: A1